NCT03967795View on ClinicalTrials.gov

Citrullinemia for the Prediction of Enteral Nutrition Tolerance Among Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

November 28, 2019

Primary Completion Date

March 27, 2023

Study Completion Date

April 24, 2023

Conditions
Enteral NutritionIntensive Care UnitBiomarkers
Interventions
DRUG

N2-L-Alanyl-L-Glutamine (Substance)

20 gr of 10% N2-L-Alanyl-L-Glutamine, dilution in 200 ml of water for injection, intravenous perfusion over 30 minutes

Trial Locations (1)

25030

Chu de Besancon, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT03967795 - Citrullinemia for the Prediction of Enteral Nutrition Tolerance Among Critically Ill Patients | Biotech Hunter | Biotech Hunter